IL-4i1 Regulation of Immune Protection During Mycobacterium tuberculosis Infection.

导出 OA

翻译打印收藏纠错

第一作者： Lerato,Hlaka

第一单位： International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Cape Town, South Africa.

作者： Lerato,Hlaka ^[1] ; Mumin,Ozturk ^[2] ; Julius E,Chia ^[3] ; Shelby-Sara,Jones ^[1] ; Shandre,Pillay ^[2] ; Sibongiseni K L,Poswayo ^[1] ; Thabo,Mpotje ^[2] ; Justin K,Nono ^[1] ; Simphiwe R N,Simelane ^[2] ; Suraj P,Parihar ^[1] ; Sugata,Roy ^[2] ; Harukazu,Suzuki ^[1] ; Frank,Brombacher ^[2] ; Reto,Guler ^[1]

作者单位： International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Cape Town, South Africa. ^[1] Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa. ^[2] The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA. ^[3] Laboratory of ImmunoBiology and Helminth Infections, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation, Yaoundé, Cameroon. ^[4] Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. ^[5] RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. ^[6]

关键词 Mycobacterium tuberculosis IL-4i1 host-directed therapy immunity